Cambridge Investment Research Advisors, Inc. - ACLARIS THERAPEUTICS INC ownership

Back to all holdings Add to watchlist

ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 83 filers reported holding ACLARIS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.08 and the average weighting 0.4%.

Links
Filings
External links
Quarter-by-quarter ownership
Cambridge Investment Research Advisors, Inc. ownership history of ACLARIS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$105
-34.0%
15,3380.0%0.00%
-100.0%
Q2 2023$159
+28.2%
15,3380.0%0.00%0.0%
Q1 2023$124
-48.8%
15,3380.0%0.00%0.0%
Q4 2022$242
-99.9%
15,338
-1.3%
0.00%0.0%
Q3 2022$245,000
+14.5%
15,538
+1.3%
0.00%0.0%
Q2 2022$214,000
-18.9%
15,3380.0%0.00%0.0%
Q1 2022$264,000
+18.4%
15,3380.0%0.00%0.0%
Q4 2021$223,000
-19.2%
15,3380.0%0.00%0.0%
Q3 2021$276,000
+7.0%
15,338
+4.3%
0.00%0.0%
Q2 2021$258,000
-30.3%
14,7000.0%0.00%
-50.0%
Q1 2021$370,000
+27.6%
14,700
-67.2%
0.00%0.0%
Q4 2020$290,000
+152.2%
44,773
+0.2%
0.00%
+100.0%
Q3 2020$115,000
+59.7%
44,7000.0%0.00%0.0%
Q2 2020$72,000
+56.5%
44,7000.0%0.00%–
Q1 2020$46,000
-45.2%
44,7000.0%0.00%
-100.0%
Q4 2019$84,000
+75.0%
44,7000.0%0.00%–
Q3 2019$48,000–44,700–0.00%–
 Download
Other shareholders
ACLARIS THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Foresite Capital Management V, LLC 1,258,243$8,618,96513.75%
Foresite Capital Management IV, LLC 2,808,034$19,235,03310.68%
Bain Capital Life Sciences Investors, LLC 3,400,000$23,290,0002.60%
GREAT POINT PARTNERS LLC 1,691,768$11,588,6112.11%
Samsara BioCapital, LLC 696,171$4,768,7711.46%
Altium Capital Management LP 403,000$2,760,5501.44%
BVF INC/IL 7,064,736$48,393,4421.30%
Aisling Capital Management LP 434,455$2,976,0171.23%
GREAT POINT PARTNERS LLC 700,000$4,795,0000.87%
VR Adviser, LLC 1,040,754$7,129,1650.75%
View complete list of ACLARIS THERAPEUTICS INC shareholders